Evidence suggests that including patients as active members of the care team has a positive impact on long-term outcomes. Successful education delivery has been shown to increase patient and caregiver self-efficacy, decrease distress for the transplantation process, and increases patient satisfaction.

Although the toxicity profiles of the newer molecularly targeted drugs are less focused on blood cells than those of traditional cytotoxic therapies, there are still infectious risks; safety and efficacy can only be guaranteed by multidisciplinary teams that have therapeutic expertise in the pharmacology of oral anti-cancer therapy.

Early identification of patients’ interventional needs may decrease their morbidity and mortality, increase quality of life, improve patient-clinician communication, and decrease health care utilization and associated costs.

Current practices that foster nursing resilience need to be evaluated, recognized, enhanced and supported by management and institutional leadership.  Protocols need to be put in place to ensure that nursing and other health care staff have access to support and resources needed to persevere through this challenging time.​​​​​​​

Continued education for oncology care providers is necessary to promote awareness of the cardiac effects of hematologic malignancies and their treatment so that effective methods of management may be implemented.

Educating physicians and oncology nurses about the requirements and advantages of an outpatient HCT program would enable the implementation of this program in their institution and help identify appropriate patients who could benefit from this treatment approach.

In collaboration with the medical oncologists and other multidisciplinary team members, nurses and pharmacists should participate in efforts to optimize the oral anticancer therapy protocol of the individual patient with the appropriate management of medication-related side effects and reducing the complexity of regimen.

In collaboration with the medical oncologists and other multidisciplinary team members, nurses and pharmacists should participate in efforts to optimize the oral anticancer therapy protocol of the individual patient with the appropriate management of medication-related side effects and reducing the complexity of regimen.

In order to improve smoking cessation efforts, health care providers need to understand options for smoking cessation therapy as well as the clinical data supporting these interventions. Pharmacists can play a critical role in patient education, therapy recommendations, and therapy management for smoking cessation.